PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma–paraganglioma origin. Issue 11 (28th September 2020)
- Record Type:
- Journal Article
- Title:
- PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma–paraganglioma origin. Issue 11 (28th September 2020)
- Main Title:
- PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma–paraganglioma origin
- Authors:
- Remes, Satu Maria
Leijon, Helena
Vesterinen, Tiina
Louhimo, Johanna
Pulkkinen, Ville
Ezer, Sini
Kere, Juha
Haglund, Caj
Arola, Johanna - Abstract:
- Abstract : Neuroendocrine tumors (NETs) are often diagnosed from the metastases of an unknown primary tumor. Specific immunohistochemical (IHC) markers indicating the location of a primary tumor are needed. The proprotein convertase subtilisin/kexin type 2 (PCSK2) is found in normal neural and neuroendocrine cells, and known to express in NETs. We investigated the tissue microarray (TMA) of 86 primary tumors from 13 different organs and 9 metastatic NETs, including primary tumor‐metastasis pairs, for PCSK2 expression with polymer‐based IHC. PCSK2 was strongly positive in all small intestine and appendiceal NETs, the so‐called midgut NETs, in most pheochromocytomas and paragangliomas, and in some of the typical and atypical pulmonary carcinoid tumors. NETs showing strong positivity were re‐evaluated in larger tumor cohorts confirming the primary observation. In the metastases, the expression of PCSK2 mirrored that of the corresponding primary tumors. We found negative or weak staining in NETs from the thymus, gastric mucosa, pancreas, rectum, thyroid, and parathyroid. PCSK2 expression did not correlate with Ki‐67 in well‐differentiated NETs. Our data suggest that PCSK2 positivity can indicate the location of the primary tumor. Thus, PCSK2 could function in the IHC panel determined from screening metastatic NET biopsies of unknown primary origins.
- Is Part Of:
- Apmis. Volume 128:Issue 11(2020)
- Journal:
- Apmis
- Issue:
- Volume 128:Issue 11(2020)
- Issue Display:
- Volume 128, Issue 11 (2020)
- Year:
- 2020
- Volume:
- 128
- Issue:
- 11
- Issue Sort Value:
- 2020-0128-0011-0000
- Page Start:
- 563
- Page End:
- 572
- Publication Date:
- 2020-09-28
- Subjects:
- Neuroendocrine tumors -- primary origin -- PCSK2 -- immunohistochemistry
Pathology -- Periodicals
Microbiology -- Periodicals
Immunology -- Periodicals
572 - Journal URLs:
- http://www.blackwell-synergy.com/loi/apm ↗
https://onlinelibrary.wiley.com/journal/16000463 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/apm.13071 ↗
- Languages:
- English
- ISSNs:
- 0903-4641
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1568.740000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 14428.xml